Cinclus Pharma (CINPHA)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 12.52 |
|---|---|
| 52-week range | 10.48 – 19.64 |
| Return, 1 month / 3 months | +8.9% / +4.2% |
| Return, 1 year / 3 years | −23.6% / – |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 44.3% |
| Worst drawdown (1 year) | -44.4% |
| Average daily value traded | 0.66M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Cinclus Pharma (CINPHA) trades on the Stockholm Exchange in Sweden. It last closed at SEK 12.52 on 19 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 560 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 23.6% and over the last three months it rose 4.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.2% | ||
| From 52-week high | -35.7% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 4.2% | ||
| 6-month return | -26.5% | ||
| 12-month return, skipping the last month | -29.8% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 44.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.4% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.66M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −1.9% |
|---|---|
| 1 month | +8.9% |
| 3 months | +4.2% |
| 6 months | −26.5% |
| 1 year | −23.6% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 12.61 / 14.11 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.58 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.